Searched for
COHANCE LIFESCIENCES BUY
Small & midcaps tumble! Hindustan Copper, Devyani, PI Industries, other stocks fall up to 7%Smallcap and midcap stocks came under pressure on Wednesday as broader markets weakened amid a record low rupee, elevated bond yields, and ...- Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4Cohance Lifesciences shares dropped significantly after reporting an 84% year-on-year decline in March-quarter net profit. Jefferies downgr...
- Anand James’ top picks: Why Time Techno and Shyam Metalics are buys this weekGeojit’s Anand James sees Nifty stabilizing despite volatility, with a potential move toward 25,600. While banking stocks remain weak, sele...
- Small-cap stocks rebound in April with best month in a decadeIndia's small-cap stocks experienced their strongest monthly rally in at least a decade during April, recovering significantly after a shar...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian stock markets saw a strong upward trend on Wednesday. The Nifty 50 and Sensex both closed higher, driven by gains in auto, FMCG, and...
- What war? Smallcap stocks defy Middle East tensions with up to 56% gains in 2 months as Nifty slidesDespite Middle East tensions and a sliding Nifty50, India's smallcap stocks have surged up to 56% in two months. While institutional desks ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
- Ahead of Market: 10 things that will decide stock market action on MondayDomestic markets extended gains with Nifty closing above 24,000, led by banking, auto, and consumer stocks. Easing volatility and bullish t...
- For stock hunters: In Rs 10 lakh crore Friday market crash, 50 stocks rally against Iran war sell-offDespite a Rs 10 lakh crore market wipeout triggered by the Iran conflict, nearly 50 stocks showed resilience. Select gainers—including ACME...
- Risk-on trade back? Smallcap stocks rally up to 28% in 2026, but market breadth stays weakSmallcap stocks are showing signs of a comeback after a dull 2025, driven by attractive valuations and improving earnings. The India-US tra...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets rebounded to end a five-day losing streak as trade optimism with the US lifted sentiment. Sensex and Nifty closed higher, su...
- Mutual funds load up on bank stocks in September, buy Kotak and ICICI Bank shares worth over Rs 3,000 croreMutual funds reduced cash reserves slightly in September. Key banks like Kotak and ICICI saw additions. Investors bought into HDFC Bank and...
- Jefferies' pharma bets are Divi's Laboratories and 3 smallcaps, with up to 30% upside. Here's whyJefferies expects India’s CRDMO sector to see strong growth over 3–5 years, recommending Divi’s Labs, Cohance Lifesciences, Sai Life Scienc...
- Stocks to buy in 2025 for long term: Cohance Lifesciences, Divi’s Lab among 5 stocks that could give 10-30% returnBrokerages remain upbeat on select stocks across sectors, rolling out fresh Buy calls with healthy upside potential.
- Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendationCohance Lifesciences, Divi’s Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with ‘Buy’ ratings, citing stro...
- Exploring the Growth Potential of the Indian Pharmaceutical SectorThe Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...
- ADIA, HarbourVest eye minor stake in CohanceADIA and HarbourVest are in discussions to acquire a minority stake in Cohance Lifesciences, a pharmaceuticals platform owned by Advent Int...
- Suven Pharma falls 2% as Advent picks majority stake in the companyPost the completion of this acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences with Suven, to...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent closes in on Suven Pharma buyoutPromoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...
Load More
